Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Platelet-rich fibrin to reduce pain after lumbar disc surgery

Official title: Efficacy of Platelet Rich Fibrin in the Prevention of Residual Neuropathic Pain Following Disc Herniation Surgery

Run by University Hospital, Strasbourg, France · NCT05196503 · Data updated 2026-11-12

This phase 3 trial tests whether applying platelet-rich fibrin around the nerve roots during lumbar disc surgery can lessen ongoing neuropathic pain after the operation.

More Neuropathic Pain trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg, Bas-Rhin)
StatusRecruiting
StartedFebruary 23, 2022
Main results expectedFebruary 23, 2022
Study endsJanuary 2028
Registry record updatedJune 8, 2026
Trial IDNCT05196503 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing lumbar disc herniation surgery who have radiating leg pain due to radiculopathy and meet the study’s inclusion criteria.

Probably not a fit

Patients who do not respond to PRF or who have exclusion criteria or complications related to surgery may not experience pain relief.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind, phase 3 study compares adding periradicular platelet-rich fibrin (PRF) during lumbar disc herniation surgery to the standard surgical approach. Participants are adults with lumbar radiculopathy planned for surgery and are assigned to receive either PRF or usual care. Outcomes are evaluated by a blinded assessor to determine the effect on residual post-surgical neuropathic pain. The trial is conducted at a single center in Strasbourg, France, and is sponsored by the University Hospital Strasbourg. Safety and tolerability of the intraoperative PRF application are also monitored.

Why it matters

Potential benefit: If successful, patients may experience lower intensity of residual neuropathic pain after surgery.

How similar studies have gone: Previous approaches using platelet-rich therapies in regenerative contexts show potential for pain reduction, but this exact intraoperative application is relatively novel and requires confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Patient, male or female, \>18 years old at the time of signing informed consent;
* Patient for whom a diagnosis of radiculopathy on lumbar disc herniation has been made, and for whom surgery has been scheduled in the Neurosurgery department;
* Patient affiliated to a social security health insurance scheme;
* Patient able to understand the objectives and risks of research and to give informed, dated and signed consent;
* Patient having been informed of the results of the prior medical examination;
* Women of childbearing age provided that a negative blood pregnancy test is recorded at the inclusion visit and effective contraception used throughout the study.

Exclusion criteria:

* Patient with a history of lumbar spinal surgery (multiple herniated discs, herniated disc other than lumbar);
* Patient with HIV, active cancer, HBV, HCV (verified by interview);
* Patient on long-term systemic corticosteroid therapy;
* Patient with an ASA score \> 3 during the consultation with the anesthesiologist;
* Inability to give the patient informed information (patient in an emergency or life-threatening situation, difficulties in understanding);
* Patient in exclusion period (determined by a previous or ongoing study);
* Subject under safeguard of justice;
* Subject under curatorship;
* Pregnancy;
* Breastfeeding.

Where it's running

  • Les Hôpitaux Universitaires
    Strasbourg, Bas-Rhin, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.